84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]徐善強,張宇,張文舉,等.距舟楔關(guān)節(jié)融合結(jié)合同種異體骨植骨治療Müller-Weiss病[J].中醫(yī)正骨,2021,33(05):65-67.
　XU Shanqiang,ZHANG Yu,ZHANG Wenju,et al.Talonavicular-cuneonavicular arthrodesis combined with allogeneic bone grafting for treatment of Müller-Weiss disease[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(05):65-67.
點擊復制

距舟楔關(guān)節(jié)融合結(jié)合同種異體骨植骨治療Müller-Weiss病()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第33卷
期數(shù):
2021年05期
頁碼:
65-67
欄目:
臨床報道
出版日期:
2021-05-20

文章信息/Info

Title:
Talonavicular-cuneonavicular arthrodesis combined with allogeneic bone grafting for treatment of Müller-Weiss disease
作者:
徐善強; 張宇; 張文舉; 李平; 王勇; 何凱元
(四川省骨科醫(yī)院,四川 成都 610041)
Author(s):
XU Shanqiang; ZHANG Yu; ZHANG Wenju; LI Ping; WANG Yong; HE Kaiyuan
關(guān)鍵詞:
骨壞死;  跗骨;  關(guān)節(jié)融合術(shù);  骨移植;  Müller-Weiss病
摘要:
目的:觀察距舟楔關(guān)節(jié)融合結(jié)合同種異體骨植骨治療Müller-Weiss病的臨床療效及安全性。方法:2017年12月至2019年3月,采用距舟楔關(guān)節(jié)融合結(jié)合同種異體骨植骨治療Müller-Weiss病患者18例。男4例,女14例。年齡43～66歲,中位數(shù)55歲。左側(cè)10例,右側(cè)8例。根據(jù)Maceira分期標準,Ⅲ期6例、Ⅳ期12例。病程13～72個月,中位數(shù)36個月。進行患足負重位X線檢查,測量側(cè)位距骨第一跖骨角、正位距骨第二跖骨角。進行患足后足力線位X線檢查,測量后足力線角。采用視覺模擬量表(visual analogue scale,VAS)評分評價患足疼痛程度,采用美國足踝外科協(xié)會(American Orthopaedic Foot and Ankle Society,AOFAS)中足評分標準評價綜合療效。隨訪觀察關(guān)節(jié)融合及并發(fā)癥發(fā)生情況。結(jié)果:1例患者出現(xiàn)切口延遲愈合,加強換藥后切口愈合。所有患者均獲隨訪,隨訪時間13～22個月,中位數(shù)18個月。距舟楔關(guān)節(jié)均獲得骨性融合,融合時間12～16周,中位數(shù)14周。與術(shù)前相比,末次隨訪時患足疼痛VAS評分降低[(6.3±1.5)分,(0.9±0.1)分,t=7.082,P=0.002],AOFAS評分增高[(41.3±9.7)分,(86.8±10.1)分,t=11.078,P=0.001],側(cè)位距骨第一跖骨角、正位距骨第二跖骨角、后足力線角均有改善(-2.66°±7.20°,0.18°±1.52°,t=1.058,P=0.012; 22.45°±1.67°,0.68°±0.12°,t=2.111,P=0.004; -16.67°±4.85°,0.12°±1.20°,t=10.214,P=0.002)。所有患者均未出現(xiàn)切口感染、皮膚壞死及內(nèi)固定物斷裂并發(fā)癥。結(jié)論:距舟楔關(guān)節(jié)融合結(jié)合同種異體骨植骨治療Müller-Weiss病,可以緩解足部疼痛、矯正足部畸形,且關(guān)節(jié)融合率高、短期綜合療效好、并發(fā)癥少。

參考文獻/References:

[1] 孫剛,陳秀林,孫海濱,等.距舟關(guān)節(jié)融合術(shù)治療Ⅲ、Ⅳ期Müller-Weiss病[J].中醫(yī)正骨,2020,32(6):71-72.
[2] MONTEAGUDO M,MACEIRA E.Management of Müller-Weiss disease[J].Foot Ankle Clin,2019,24(1):89-105.
[3] MACEIRA E,ROCHERA R.Müller-Weiss disease:clinical and biomechanical features[J].Foot Ankle Clin,2004,9(1):105-125.
[4] LI S Y,MYERSON M S,MONTEAGUDO M,et al.Efficacy of calcaneus osteotomy for treatment of symptomatic Müller-Weiss disease[J].Foot Ankle Int,2017,38(3):261-269.
[5] HARNROONGROJ T,CHUCKPAIWONG B.Müller-Weiss-disease:three-to-eight-year follow-up outcomes of isolated talonavicular arthrodesis[J].J Foot Ankle Surg,2018,57(5):1014-1019.
[6] 蔣協(xié)遠,王大偉.骨科臨床療效評價標準[M].北京:人民衛(wèi)生出版社,2005:233-234.
[7] TOSUN B,AL F,TOSUN A.Spontaneous osteonecrosis of the tarsal navicular in an adult:Mueller-Weiss syndrome[J].J Foot Ankle Surg,2011,50(2):221-224.
[8] YU G,ZHAO Y,ZHOU J,et al.Fusion of talonavicular and naviculocuneiform joints for the treatment of Müller-Weiss disease[J].J Foot Ankle Surg,2012,51(4):415-419.
[9] 胡東,張言,梁曉軍,等.單純距舟關(guān)節(jié)融合術(shù)治療Müller-Weiss病療效分析[J].中國修復重建外科雜志,2017,31(12):1434-1437.
[10] JANOSITZ G,SISáK K,TTH K.Percutaneous decompression for the treatment of Mueller-Weiss syndrome[J].Knee Surg Sports Traumatol Arthrosc,2011,19(4):688-690.
[11] WANG X,MA X,ZHANG C,et al.Flatfoot in Muller-Weiss syndrome:a case series[J].J Med Case Rep,2012,6:228.
[12] DOYLE T,NAPIER R J,WONG-CHUNG J.Recognition and management of Muller-Weiss disease[J].Foot Ankle Int,2012,33(4):275-281.
[13] RUIZ-ESCOBAR J,VILADOT-PERIC R,áLVAREZ-GOENAGA F,et al.Treatment with plantar supports in Müller-Weiss disease.Preliminary report[J].Acta Ortop Mex,2020,34(2):112-118.
[14] CAO H H,LU W Z,TANG K L.Isolated talonavicular arthrodesis and talonavicular-cuneiform arthrodesis for the Muller-Weiss disease[J].J Orthop Surg Res,2017,12(1):83.
[15] LU C K,FU Y C,CHENG Y M,et al.Isolated talonavicular arthrodesis for Müller-Weiss disease[J].Kaohsiung J Med Sci,2014,30(9):471-476.
[16] LUI T H.Arthroscopic triple arthrodesis in patients with Müller Weiss disease[J].Foot Ankle Surg,2009,15(3):119-122.
[17] HETSRONI I,NYSKA M,AYALON M.Plantar pressure distribution in patients with Müller-Weiss disease[J].Foot Ankle Int,2007,28(2):237-241.

相似文獻/References:

[1]劉文東,辛景義.微型鈦板內(nèi)固定治療Lisfranc損傷[J].中醫(yī)正骨,2016,28(10):52.
[2]黃偉軍,趙凱,李志民,等.切開復位螺釘內(nèi)固定治療Lisfranc損傷[J].中醫(yī)正骨,2016,28(11):50.
[3]蔣巧玲,郭水潔,葉艷君,等.應用SPECT-CT圖像融合技術(shù)評價锝〖99Tc〗-亞甲基二膦酸鹽治療距骨缺血性壞死的臨床療效[J].中醫(yī)正骨,2017,29(02):31.
[4]申震,董瑋,黃雅靜,等.不同中醫(yī)證候膝關(guān)節(jié)自發(fā)性骨壞死患者脂代謝特征的對比研究[J].中醫(yī)正骨,2022,34(09):1.
　SHEN Zhen,DONG Wei,HUANG Yajing,et al.Lipid metabolism characteristics of spontaneous knee osteonecrosis patients with different traditional Chinese medicine syndromes:a comparative study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(05):1.
[5]孫剛,陳秀林,孫海濱,等.距舟關(guān)節(jié)融合術(shù)治療Ⅲ、Ⅳ期Müller-Weiss病[J].中醫(yī)正骨,2020,32(06):71.
[6]王勇,張宇,張文舉,等.距舟-舟楔關(guān)節(jié)融合聯(lián)合自體髂骨植骨治療MaceiraⅣ、Ⅴ期Müller-Weiss病[J].中醫(yī)正骨,2022,34(01):73.

更新日期/Last Update: 1900-01-01